Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001649989-25-000003

Options or other derivatives

  • Director acquired 404,030 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Sukhtian Faisal Ghiath · Director

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2025-10-01 Grant or award : show line 1 in the form Stock Option (Right to Buy) +286,734 286,734 D
2025-10-03 Grant or award : show line 2 in the form Stock Option (Right to Buy) +117,296 117,296 D
Loading xslF345X05/primary_doc.xml…